Nasal in-situ Transferosomes as a Platform Technology for Nose-to-Brain Drug Delivery
The blood-brain barrier (BBB) represents a major obstacle in the therapeutic management of disorders related to the central nervous system (CNS), blocking the access of almost 98% of small molecule medications and practically all large molecules. Intranasal drug administration represents a viable alternative to overcom...